BioCentury
ARTICLE | Clinical News

Celebrex celecoxib: Marketed

April 24, 2000 7:00 AM UTC

Searle and partner Pfizer Inc. (PFE, New York, N.Y.) reported data from a 13-month 8,000-patient study comparing 800 mg/day Celebrex (4 and 2 times the recommended OA and RA doses, respectively) to 2...